tiprankstipranks
Trending News
More News >
Arno Therapeutics Inc (ARNI)
OTHER OTC:ARNI
US Market

Arno Therapeutics (ARNI) Income Statement

Compare
8 Followers

Arno Therapeutics Income Statement

Last quarter (Q3 2016), Arno Therapeutics's total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Arno Therapeutics's net income was $-3.85M. See Arno Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 0.00$ 0.00$ 0.00$ 0.00
Depreciation and Amortization
$ 228.49K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income
$ 0.00$ 0.00$ 0.00$ 0.00
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00
Pretax Income
$ 0.00$ 0.00$ 0.00$ 0.00
Net Income
$ 0.00$ 0.00$ 0.00$ 0.00
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
44.71M 44.71M 44.71M 44.71M
Weighted Average Shares Outstanding (Diluted)
44.71M 44.71M 44.71M 44.71M
Currency in USD

Arno Therapeutics Earnings and Revenue History